Vietnam’s National Health Plan Suffers Sharp Rise In Drug Prices
This article was originally published in PharmAsia News
Executive Summary
Vietnam's national health insurance fund expects to run a deficit for this year and blames fast-rising drug prices charged by hospitals and others. The Vietnam Social Insurance Agency said prices for cancer drugs and other special treatments have increased by as much as 50 percent over the market price. The cause of sharp rise in prices is blamed in part on a lack of open bidding for the supplies and illegal prices adopted by hospitals. (Click here for more